These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 20488610

  • 1. Unstable wide complex tachycardia during propafenone therapy.
    Tsai CF, Sia SK, Lin MC, Wu DJ, Ueng KC.
    Resuscitation; 2010 Aug; 81(8):1046-7. PubMed ID: 20488610
    [No Abstract] [Full Text] [Related]

  • 2. [Persistent atrial flutter induced by propafenone (Rytmonorm)].
    Fazekas T, Kiss J, Pap I, Rudas L.
    Orv Hetil; 1994 Aug 14; 135(33):1819-22. PubMed ID: 8072758
    [Abstract] [Full Text] [Related]

  • 3. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M.
    Kardiol Pol; 2008 Nov 14; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [Abstract] [Full Text] [Related]

  • 4. Atrial flutter with 1:1 atrioventricular conduction caused by propafenone.
    el-Harari MB, Adams PC.
    Pacing Clin Electrophysiol; 1998 Oct 14; 21(10):1999-2001. PubMed ID: 9793099
    [Abstract] [Full Text] [Related]

  • 5. The Wrong Drug That Led to the Right Diagnosis.
    Bergonti M, Assanelli E, Agostoni P.
    Circulation; 2019 Nov 05; 140(19):1601-1604. PubMed ID: 31682531
    [No Abstract] [Full Text] [Related]

  • 6. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC, Ansink JM, van Veldhuisen DJ, van Gelder IC.
    Int J Cardiol; 2006 Feb 08; 107(1):140-1. PubMed ID: 15990183
    [No Abstract] [Full Text] [Related]

  • 7. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP.
    Arch Mal Coeur Vaiss; 1995 Dec 08; 88(12):1869-74. PubMed ID: 8729368
    [Abstract] [Full Text] [Related]

  • 8. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
    Tai CT, Chiang CE, Lee SH, Chen YJ, Yu WC, Feng AN, Ding YA, Chang MS, Chen SA.
    J Cardiovasc Electrophysiol; 1999 Sep 08; 10(9):1180-7. PubMed ID: 10517649
    [Abstract] [Full Text] [Related]

  • 9. Atrial flutter in patients treated for atrial fibrillation with propafenone.
    Murdock CJ, Kyles AE, Yeung-Lai-Wah JA, Qi A, Vorderbrugge S, Kerr CR.
    Am J Cardiol; 1990 Sep 15; 66(7):755-7. PubMed ID: 2399896
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 11. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
    G Ital Cardiol; 1996 Apr 01; 26(4):379-90. PubMed ID: 8707022
    [Abstract] [Full Text] [Related]

  • 12. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393
    [Abstract] [Full Text] [Related]

  • 13. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias.
    Rae AP.
    Am J Cardiol; 1998 Oct 16; 82(8A):59N-65N. PubMed ID: 9809902
    [Abstract] [Full Text] [Related]

  • 14. [Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, Beurrier D, Houplon P, Louis P, Danchin N.
    Arch Mal Coeur Vaiss; 1997 Jul 16; 90(7):961-6. PubMed ID: 9339257
    [Abstract] [Full Text] [Related]

  • 15. Deglutition induced atrial tachycardia and atrial fibrillation.
    Kanjwal Y, Imran N, Grubb B.
    Pacing Clin Electrophysiol; 2007 Dec 16; 30(12):1575-8. PubMed ID: 18070318
    [Abstract] [Full Text] [Related]

  • 16. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH, EURIDIS and ADONIS Investigators.
    N Engl J Med; 2007 Sep 06; 357(10):987-99. PubMed ID: 17804843
    [Abstract] [Full Text] [Related]

  • 17. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 06; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group.
    Podrid PJ, Anderson JL.
    Am J Cardiol; 1996 Aug 15; 78(4):430-4. PubMed ID: 8752188
    [Abstract] [Full Text] [Related]

  • 19. Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery.
    Geelen P, O'Hara GE, Roy N, Talajic M, Roy D, Plante S, Turgeon J.
    Am J Cardiol; 1999 Aug 01; 84(3):345-7, A8-9. PubMed ID: 10496451
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
    Cardiol J; 2009 Aug 01; 16(6):521-7. PubMed ID: 19950088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.